2023Q1营收大幅下滑59.4%,营业利润下滑94.6%,净利润几乎归零。
目前市盈率8.5,市盈率TTM已经飙升到23.4,可以多看几个季度再做判断。查看全文
$PROPHASE LABS INC(PRPH)$ UPLOAD [Cover] - SEC-generated letter Filed: 2017-02-14 AccNo: 0000000000-17-005279 Size: 136 KB 网页链接
$PROPHASE LABS INC(PRPH)$ 8-K - Current report Filed: 2017-04-06 AccNo: 0001493152-17-003587 Size: 51 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$PROPHASE LABS INC(PRPH)$ 8-K - Current report Filed: 2017-03-29 AccNo: 0001493152-17-002984 Size: 1 MBItem 1.01: Entry into a Material Definitive AgreementItem 1.02: Termination of a Material Definitive AgreementItem 2.01: Completion of Acquisition or Disposition of AssetsIt...
$PROPHASE LABS INC(PRPH)$ DEF 14A - Other definitive proxy statements Filed: 2017-03-03 AccNo: 0001493152-17-002086 Size: 2 MB 网页链接
$PROPHASE LABS INC(PRPH)$ 8-K - Current report Filed: 2017-02-27 AccNo: 0001493152-17-001963 Size: 97 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$PROPHASE LABS INC(PRPH)$ PRER14A - Preliminary Proxy Soliciting materials Filed: 2017-02-24 AccNo: 0001493152-17-001892 Size: 2 MB 网页链接
$PROPHASE LABS INC(PRPH)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2017-02-24 AccNo: 0001493152-17-001890 Size: 4 MB 网页链接
$PROPHASE LABS INC(PRPH)$ CT ORDER - Confidential treatment order Filed: 2017-02-16 AccNo: 9999999997-17-000803 Size: 10 KB 网页链接
$PROPHASE LABS INC(PRPH)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2017-02-02 AccNo: 0001140361-17-004119 Size: 148 KB 网页链接
$PROPHASE LABS INC(PRPH)$ PRE 14A - Other preliminary proxy statements Filed: 2017-01-31 AccNo: 0001493152-17-000987 Size: 2 MB 网页链接